657 related articles for article (PubMed ID: 12030787)
1. Effects of captopril and losartan on myocardial ischemia-reperfusion induced arrhythmias and necrosis in rats.
Ozer MK; Sahna E; Birincioglu M; Acet A
Pharmacol Res; 2002 Apr; 45(4):257-63. PubMed ID: 12030787
[TBL] [Abstract][Full Text] [Related]
2. Effects of captopril and angiotensin II receptor blockers (AT1, AT2) on myocardial ischemia-reperfusion induced infarct size.
Parlakpinar H; Ozer MK; Acet A
Cytokine; 2011 Dec; 56(3):688-94. PubMed ID: 21975128
[TBL] [Abstract][Full Text] [Related]
3. Comparative effects of pretreatment with captopril and losartan on cardiovascular protection in a rat model of ischemia-reperfusion.
Zhu B; Sun Y; Sievers RE; Browne AE; Pulukurthy S; Sudhir K; Lee RJ; Chou TM; Chatterjee K; Parmley WW
J Am Coll Cardiol; 2000 Mar; 35(3):787-95. PubMed ID: 10716484
[TBL] [Abstract][Full Text] [Related]
4. Comparative effects of aspirin with ACE inhibitor or angiotensin receptor blocker on myocardial infarction and vascular function.
Zhu BQ; Sievers RE; Browne AE; Lee RJ; Chatterjee K; Grossman W; Karliner JS; Parmley WW
J Renin Angiotensin Aldosterone Syst; 2003 Mar; 4(1):31-7. PubMed ID: 12692751
[TBL] [Abstract][Full Text] [Related]
5. Effects of captopril on ischaemia-reperfusion-induced arrhythmias in an in vivo rat model.
Olmez E; Birincioglu M; Aksoy T; Acet A
Pharmacol Res; 1995; 32(1-2):37-41. PubMed ID: 8668645
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II inhibition during myocardial ischemia-reperfusion in dogs: effects on leukocyte infiltration, nitric oxide synthase isoenzymes activity and left ventricular ejection fraction.
de Gusmão FM; Becker C; Carvalho MH; Barros LF
Int J Cardiol; 2005 Apr; 100(3):363-70. PubMed ID: 15837077
[TBL] [Abstract][Full Text] [Related]
7. The role of prostaglandin synthesis stimulation in the protective effect of captopril on ischaemia-reperfusion arrhythmias in rats in vivo.
Birincioglu M; Olmez E; Aksoy T; Acet A
Pharmacol Res; 1997 Oct; 36(4):299-304. PubMed ID: 9425619
[TBL] [Abstract][Full Text] [Related]
8. Losartan attenuates myocardial ischemia-induced ventricular arrythmias and reperfusion injury in spontaneously hypertensive rats.
Lee YM; Peng YY; Ding YA; Yen MH
Am J Hypertens; 1997 Aug; 10(8):852-8. PubMed ID: 9270079
[TBL] [Abstract][Full Text] [Related]
9. Influence of ramiprilat and losartan on ischemia reperfusion injury in rat hearts.
Safari F; Hajizadeh S; Shekarforoush S; Bayat G; Foadoddini M; Khoshbaten A
J Renin Angiotensin Aldosterone Syst; 2012 Mar; 13(1):29-35. PubMed ID: 22076778
[TBL] [Abstract][Full Text] [Related]
10. Chronic pantoprazole administration and ischemia--reperfusion arrhythmias in vivo in rats--antiarrhythmic or arrhythmogenic?
Abdel-Kawy HS
Cardiovasc Ther; 2015 Apr; 33(2):27-34. PubMed ID: 25677801
[TBL] [Abstract][Full Text] [Related]
11. EXP3174, the AII antagonist human metabolite of losartan, but not losartan nor the angiotensin-converting enzyme inhibitor captopril, prevents the development of lethal ischemic ventricular arrhythmias in a canine model of recent myocardial infarction.
Lynch JJ; Stump GL; Wallace AA; Painter CA; Thomas JM; Kusma SE; Gould RJ; Grossman W
J Am Coll Cardiol; 1999 Sep; 34(3):876-84. PubMed ID: 10483973
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of taurine against reperfusion-induced arrhythmias in isolated ischemic rat heart.
Chahine R; Feng J
Arzneimittelforschung; 1998 Apr; 48(4):360-4. PubMed ID: 9608877
[TBL] [Abstract][Full Text] [Related]
13. Tempol reduces reperfusion-induced arrhythmias in anaesthetized rats.
Guo R; Gao XY; Wang W; Wang HJ; Zhang F; Zhang Y; Zhu GQ
Pharmacol Res; 2005 Aug; 52(2):192-8. PubMed ID: 15967386
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Angiotensin-II Production Increases Susceptibility to Acute Ischemia/Reperfusion Arrhythmia.
Taskin E; Tuncer KA; Guven C; Kaya ST; Dursun N
Med Sci Monit; 2016 Nov; 22():4587-4595. PubMed ID: 27889788
[TBL] [Abstract][Full Text] [Related]
15. Paracrine systems in the cardioprotective effect of angiotensin-converting enzyme inhibitors on myocardial ischemia/reperfusion injury in rats.
Liu YH; Yang XP; Sharov VG; Sigmon DH; Sabbath HN; Carretero OA
Hypertension; 1996 Jan; 27(1):7-13. PubMed ID: 8591891
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of the angiotensin-converting enzyme inhibitor captopril on postischemic myocardial damage in perfused rat heart.
Takeda H; Haneda T; Kikuchi K
Jpn Circ J; 1997 Aug; 61(8):687-94. PubMed ID: 9276774
[TBL] [Abstract][Full Text] [Related]
17. Effect of combining an ACE inhibitor and an angiotensin II receptor blocker on plasma and kidney tissue angiotensin II levels.
Komine N; Khang S; Wead LM; Blantz RC; Gabbai FB
Am J Kidney Dis; 2002 Jan; 39(1):159-64. PubMed ID: 11774115
[TBL] [Abstract][Full Text] [Related]
18. Effects of the angiotensin AT1 receptor blocker candesartan on myocardial ischemic/reperfusion injury.
Shimizu M; Sjöquist PO; Wang QD; Rydén L
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S137-42. PubMed ID: 9892154
[TBL] [Abstract][Full Text] [Related]
19. Protection against in vivo focal myocardial ischemia/reperfusion injury-induced arrhythmias and apoptosis by hesperidin.
Gandhi C; Upaganalawar A; Balaraman R
Free Radic Res; 2009 Sep; 43(9):817-27. PubMed ID: 19579067
[TBL] [Abstract][Full Text] [Related]
20. The protective effects of CP-060S on ischaemia- and reperfusion- induced arrhythmias in anaesthetized rats.
Koga T; Fukazawa M; Suzuki Y; Akima M; Adachi Y; Tamura K; Kato T; Kuromaru O
Br J Pharmacol; 1998 Apr; 123(7):1409-17. PubMed ID: 9579737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
